Multiple endocrine neoplasia type 2: A review.
Mathiesen JS, Effraimidis G, Rossing M, Rasmussen ÅK, Hoejberg L, Bastholt L, Godballe C, Oturai P, Feldt-Rasmussen U.
Semin Cancer Biol. 2022 Feb;79:163-179. doi: 10.1016/j.semcancer.2021.03.035. Epub 2021 Apr 1.
Genotype/phenotype correlations in multiple endocrine neoplasia type 2.
Castinetti F, Eng C.
Endocr Relat Cancer. 2024 Nov 22;31(12):e240139. doi: 10.1530/ERC-24-0139. Print 2024 Dec 1.
Multiple Endocrine Neoplasia Type 1, Type 2A, and Type 2B.
Greenberg LA.
Prim Care. 2024 Sep;51(3):483-494. doi: 10.1016/j.pop.2024.03.006. Epub 2024 May 23.
Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results.
Machens A, Dralle H.
Curr Opin Oncol. 2024 Jan 1;36(1):1-12. doi: 10.1097/CCO.0000000000001009. Epub 2023 Nov 3.
Multiple endocrine neoplasia type 2.
Wohllk N, Schweizer H, Erlic Z, Schmid KW, Walz MK, Raue F, Neumann HP.
Best Pract Res Clin Endocrinol Metab. 2010 Jun;24(3):371-87. doi: 10.1016/j.beem.2010.02.001.
Multiple endocrine neoplasia type 2: an overview.
Moline J, Eng C.
Genet Med. 2011 Sep;13(9):755-64. doi: 10.1097/GIM.0b013e318216cc6d.
Update on multiple endocrine neoplasia Type 1 and 2.
Al-Salameh A, Baudry C, Cohen R.
Presse Med. 2018 Sep;47(9):722-731. doi: 10.1016/j.lpm.2018.03.005. Epub 2018 Jun 13.
Non-mammalian models of multiple endocrine neoplasia type 2.
Das TK, Cagan RL.
Endocr Relat Cancer. 2018 Feb;25(2):T91-T104. doi: 10.1530/ERC-17-0411.
Multiple endocrine neoplasia type 2.
Peczkowska M, Januszewicz A.
Fam Cancer. 2005;4(1):25-36. doi: 10.1007/s10689-005-0656-y.
Multiple endocrine neoplasia type 2.
Marini F, Falchetti A, Del Monte F, Carbonell Sala S, Tognarini I, Luzi E, Brandi ML.
Orphanet J Rare Dis. 2006 Nov 14;1:45. doi: 10.1186/1750-1172-1-45.
